🟢 Nuvation Bio Inc. is trading 7.94% up, likely boosted by positive commentary at Jefferies Healthcare Conference

Nuvation Bio Inc. (NUVB) is trading 7.94% higher at $5.09 in live trading, with the upward momentum appearing to be driven by investor sentiment following a company presentation.

• The move follows a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, where the company's executives participated.
• Summaries of the presentation highlighted the strong market performance of its lung cancer drug IBTROZI, advancements in its pipeline with safusidenib, and the company's solid financial position.